References
- Hodis HM, Mack WJ, Lobo RA, et al. Estrogen in the prevention of atherosclerosis: a randomized, double blind, placebo-controlled trial. Ann Intern Med 2001;135:939–53
- Harman SM, Black DM, Naftolin F, et al. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med 2014;161:249–60
- Lobo RA, Whitehead M. Too much of a good thing? Use of progestogens in the menopause: an international consensus statement. Fertil Steril 1989;51:225–31
- Manson JE, Chlebowski RT, Stefanic ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended post stopping phases of the Women's Health Initiative randomized trials. JAMA 2013;310:1353–68
- Mashchak CA, Lobo RA, Dozono-Takano R, et al. Comparison of pharmacodynamics properties of various estrogen formulations. Am J Obstet Gynecol 1982;144:511–18
- Wilcox JG, Hwang J, Hodis HN, et al. Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low density lipoprotein. Fertil Steril 1997;67:57–62
- Lobo RA, Cassidenti DL. Pharmacokenetics of oral 17 beta-estradiol. J Reprod Med 1992;37:77–84